Controlled Trial of 3 4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome (LEMS)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Lambert-Eaton Myasthenic Syndrome (LEMS) | Lambert-Eaton Myastenic Syndrome
Age: Between 4 - 100 Years
Gender: Male or Female
Diagnosed with Lambert-Eaton Myasthenic Syndrome
If female, have a negative pregnancy test and, if premenopausal, be willing to practice and effective form of birth control during this treatment
Known sensitivity to 3,4-DAP
Has a history of past or current seizures or of severe asthma
Is believed by the investigator to be unable to comply with the protocol
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required